Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nastorazepide is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 11,000 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 43,500 | |||
25 mg | 在庫あり | ¥ 83,500 | |||
50 mg | 在庫あり | ¥ 127,000 | |||
100 mg | 在庫あり | ¥ 183,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 28,500 |
説明 | Nastorazepide is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity. |
In vitro | Nastorazepide binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells[1]. |
In vivo | Nastorazepide significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Nastorazepide combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice[1]. |
別名 | Z-360 |
分子量 | 520.62 |
分子式 | C29H36N4O5 |
CAS No. | 209219-38-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (57.63 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nastorazepide 209219-38-5 GPCR/G Protein cholecystokinin CCK Receptor Cholecystokinin Receptor Inhibitor Z-360 Z360 inhibit Z 360 inhibitor